FDA Inspection 903748 — Cooperman Barnabas Medical Center Inc.

Cooperman Barnabas Medical Center Inc. — FEI 2273912

The FDA completed an inspection of Cooperman Barnabas Medical Center Inc. on November 7, 2014 in Livingston, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 7, 2014
Fiscal Year
2015
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Livingston, NJ (United States)

Citations

IDCFRDescription
442521 CFR 606.60(a)Equipment observed, standardized, calibrated